MVA.HTI
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MVA.HTI, covering 2023-07-27 to 2024-05-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals [Phase 1]